Based on the presented results, this study confirms that plasma gelsolin serves as a systemic anti-inflammatory and immunomodulatory compound with the ability to limit whole body inflammation, regardless of the type and location of the tissue in which the inflammation develops and from which the infection originates. This evidence concerns the gene GSN and infection.